McManus Matthew bought TECH
February 1, 2024 · Form 4 insider transaction
McManus Matthew bought 2,888 shares of Bio-Techne Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,888
Price
$0.00
Total value
N/A
InsiderMcManus Matthew
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 5, 2024
Shares owned after2,888
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.; Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).